TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/20/25 16:12 | 8/20/25 | CAH | Cardinal Health Inc | OH | Retail | WhDrg | Drugs, Proprietaries & Druggi | 8 | 9 | S | -50,884 | 149.09 | 0 | -341 | 429 | D | |||||||||||||||
8/20/25 16:08 | 8/18/25 | COR | Cencora, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | 4 | 14 | M.d | 23,308 | 206.03 | 0 | 113 | 42 | 384 | D | ||||||||||||||
8/20/25 16:08 | 8/18/25 | COR | Cencora, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | 4 | 14 | S.d | -23,308 | 206.03 | 0 | -113 | 384 | D | |||||||||||||||
8/19/25 10:20 | 7/11/25 | MCK | McKesson Corp | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | 5 | 17 | S.dm | -41,169 | 555.97 | 0 | -74 | 97 | D | |||||||||||||||
6/27/25 12:17 | 6/23/25 | STEK | Stemtech Corp | Retail | WhDrg | Drugs, Proprietaries & Druggi | 1 | 1 | S | -30 | 0.0300 | 0 | -1,000 | 2,134 | I | ||||||||||||||||
6/9/25 18:00 | 6/5/25 | HLF | Herbalife Ltd. | E9 | Retail | WhDrg | Drugs, Proprietaries & Druggi | 1 | 1 | P | 24 | 7.50 | 0 | 3 | 2 | 170 | D | ||||||||||||||
6/3/25 17:24 | 6/2/25 | NUS | Nu Skin Enterprises, Inc. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | 3 | 3 | S | -126 | 8.06 | 0 | -16 | 236 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |